<DOC>
	<DOCNO>NCT00006310</DOCNO>
	<brief_summary>To determine seroprevalence Kaposi 's sarcoma-associated herpesvirus ( KSHV/HHV8 ) blood donor Texas . Also examine donor ' demographic characteristic characterize KSHV use polymerase chain reaction .</brief_summary>
	<brief_title>KSHV Infection Blood Donors From Texas</brief_title>
	<detailed_description>BACKGROUND : Kaposi 's sarcoma-associated herpesvirus ( KSHV/HHV8 ) blood-borne virus etiologically associate Kaposi 's sarcoma ( KS ) , primary effusion lymphoma form non-Hodgkin 's lymphoma , subset multicentric Castleman 's disease lymphoproliferative disorder . The investigator develop serologic assay measure antibodies specific KSHV latent lytic antigen . Antibodies KSHV antigens find 70-100 percent clinical form KS patient . In contrast , relatively low prevalence ( 2 5 percent ) find general population North America . Seroconversion detect prior KS onset AIDS-KS patient , suggest primary KSHV infection occur predominantly adulthood ubiquitous . Antibody titer KSHV antigens remain elevated year seroconversion . The investigator recently find 5 percent prevalence KSHV infection blood donor San Antonio . Further , KSHV find peripheral blood mononuclear cell ( PBMC ) blood donor , organ transplantation animal study provide evidence likely person-to-person transmission KSHV . Thus , KSHV potential candidate screen blood plasma donor view etiologic role several malignancy , low appreciable prevalence general population , lifelong persistence cross-sectional study blood donor Texas . DESIGN NARRATIVE : The first aim study determine prevalence KSHV infection blood donor use specific KSHV serologic assay . The investigator use recently develop KSHV specific serologic assay detect antibody KSHV latent nuclear antigen , lytic antigen , orf65 ( lytic antigen minor capsid protein ) determine prevalence KSHV infection cross-sectional study four representative blood bank San Antonio , Dallas , Houston , Texas . A total 500 random donor site study detect site-specific seroprevalence plus minus 2 percent 95 percent confidence . The second aim study analyze demographic characteristic pattern blood-borne infection KSHV-seropositive blood donor . The cross-sectional study Houston San Antonio expand prospective study seroprevalence large population questionnaire obtain demographic data include gender , age , ethnicity , education level , household income , zip code . A total 10,500 donor obtain Houston . As San Antonio center high proportion Hispanic donor , additional 2,000 donor obtain characterize demographically . The third aim investigate KSHV molecular epidemiology blood donor sequence determination specific nested-polymerase chain reaction ( PCR ) RT-PCR product peripheral blood mononuclear cell ( PBMC ) KSHV-seropositive donor . The 2,000 blood sample San Antonio also use amplify KSHV sequence peripheral blood mononuclear cell KSHV positive donor use PCR , nest PCR RT-PCR without phorbol ester induction . Sequencing amplified product compare KSHV isolate New York , Italy , England , Africa phylogenetic analysis assessment diversity distribution KSHV strain Texas . While propose sampling represent one center Texas , comparison isolate New York abroad allow determination likelihood Texas strain unique import Europe Africa . This regional project perform collaboration University Health System Donor Center San Antonio , BloodCare Dallas , Gulf Coast Regional Blood Center Houston , thus provide result three separate metropolitan area rather different ethnic composition . These study provide valuable information ass necessity feasibility national screening blood donor KSHV , gain insight pattern infection well diversity , distribution , origins virus strain blood donor .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Sarcoma , Kaposi</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>